Clinical Trials Directory

Trials / Completed

CompletedNCT05095181

To Study the Effects of Host Genetic Factors on Liver Cirrhosis

Preventive and Personalized Medicine (2021-2023)

Status
Completed
Phase
Study type
Observational
Enrollment
1,000 (actual)
Sponsor
Asfendiyarov Kazakh National Medical University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers

Summary

The purpose of this study is to identify genetic determinants of susceptibility to liver cirrhosis . It will assist in predicting individual risks of disease progression and would help to clarify pathophysiologic mechanisms of liver cirrhosis .

Conditions

Interventions

TypeNameDescription
GENETICSNP analysis of the DNASNP analysis of the DNA obtained from peripheral blood sample

Timeline

Start date
2021-03-29
Primary completion
2023-01-20
Completion
2023-01-20
First posted
2021-10-27
Last updated
2023-03-14

Locations

1 site across 1 country: Kazakhstan

Source: ClinicalTrials.gov record NCT05095181. Inclusion in this directory is not an endorsement.